サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790272

ホスホロアミダイトの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年

Phosphoramidite Market Size, Share & Trends Analysis Report By Type (DNA Phosphoramidites, RNA Phosphoramidites), By Application (Drug Discovery & Development, Diagnostics Development), By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
ホスホロアミダイトの市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年07月31日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホスホロアミダイト市場の概要

ホスホロアミダイトの世界市場規模は2024年に11億5,000万米ドルと推定され、2033年には22億7,000万米ドルに達すると予測され、2025～2033年のCAGRは8.06%で成長すると予測されています。市場成長の背景には、オリゴヌクレオチドの生産におけるホスホルアミダイトの需要の増加、遺伝性疾患や感染症の有病率の上昇がバイオテクノロジーや製薬産業における研究開発活動の急増につながり、ホスホルアミダイトの需要をさらに促進していることがあります。

さらに、高齢者の増加とヘルスケア支出の増加も、今後数年間の市場成長を促進すると予想されています。

オリゴヌクレオチド治療の需要増加

オリゴヌクレオチドベース治療の採用が増加していることは、ホスホルアミダイト産業の主要な促進要因です。製薬会社やバイオテクノロジー企業は、アンチセンスオリゴヌクレオチド（ASO）、低分子干渉RNA（siRNA）、メッセンジャーRNA（mRNA）療法の開発に多額の投資を行っており、遺伝性疾患、感染症、希少疾患など幅広い疾患に対応しています。これらの治療法は、正確に合成されたオリゴヌクレオチドに依存しており、ホスホルアミダイトはヌクレオチド鎖を構築するために不可欠な化学中間体として機能しています。COVID-19パンデミックにおけるmRNAワクチンの成功は、合成RNAの治療可能性をさらに検証し、オリゴベース治療法の研究と規制当局の受け入れを加速させました。

ASOとsiRNAは、遺伝子発現を選択的に不活性化または調節する能力により、次世代治療として脚光を浴びています。複数のASOベース医薬品がすでに規制当局の承認を得ており、神経疾患、がん、代謝性疾患を対象とした強力なパイプラインが開発中です。治療法が核酸ベースソリューションにシフトするにつれ、高純度で修飾され、スケーラブルなホスホルアミダイトへの需要が飛躍的に高まっています。医薬品開発企業は、安全性と有効性に関する厳格な規制基準を満たす一貫した高品質のオリゴヌクレオチドを必要としており、そのため実績のある合成能力を持つ信頼できるサプライヤーへの依存度が高まっています。

さらに、mRNA治療はワクチン以外にも、腫瘍学、心血管系疾患、タンパク質代替療法などへの応用が検討されています。このような進歩に伴い、コーディング配列、修飾キャップ、調節エレメントなど、より複雑で特殊なホスホラミダイトが求められています。この動向は、確実なサプライチェーン、技術統合、品質保証を確保するため、オリゴメーカーと医薬品イノベーターとの戦略的パートナーシップを促しています。核酸医薬の世界のパイプラインが拡大し、臨床検査が加速する中、ホスホロアミダイト産業はオリゴヌクレオチド治療の基盤となる存在として、長期的な成長が期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 産業分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析

第4章 ホスホラミダイト市場：タイプビジネス分析

  • タイプセグメントダッシュボード
  • 世界のホスホラミダイト市場のタイプ変動分析
  • 世界のホスホラミダイト市場規模と動向分析（タイプ別、2021～2033年）
  • DNAホスホラミダイト
  • RNAホスホラミダイト
  • 標識ホスホラミダイト
  • 修飾ホスホラミダイト
  • その他

第5章 ホスホラミダイト市場：用途ビジネス分析

  • 用途セグメントダッシュボード
  • 世界のホスホラミダイト市場の用途変動分析
  • 世界のホスホラミダイト市場規模と動向分析（用途別、2021～2033年）
  • 医薬品の発見と開発
  • 診断開発
  • その他

第6章 ホスホラミダイト市場：最終用途ビジネス分析

  • 最終用途セグメントダッシュボード
  • 世界のホスホラミダイト市場の最終用途変動分析
  • 世界のホスホラミダイト市場規模と動向分析（最終用途別、2021～2033年）
  • 製薬バイオテクノロジー企業
  • 学術研究機関
  • その他

第7章 ホスホラミダイト市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測と動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参入企業
  • 戦略マッピング
  • 企業市況分析、2024年
  • 参入企業概要
    • BOC Sciences
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Glen Research
    • LGC Biosearch Technologies
    • Biosynth
    • BIONEER CORPORATION
    • QIAGEN
    • PolyOrg, Inc
    • Lumiprobe Corporation
図表

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 4 Global Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 5 Global Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 Global Phosphoramidite Market, By Region, 2021 - 2033 (USD Million)
  • Table 7 North America Phosphoramidite Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Phosphoramidite Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 UK Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Germany Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 France Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Italy Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Spain Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Denmark Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Denmark Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Sweden Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Sweden Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Norway Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 Norway Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Phosphoramidite Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Japan Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 China Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 India Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Australia Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Thailand Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 South Korea Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 South Korea Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 South Korea Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Phosphoramidite Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Phosphoramidite Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Africa Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 91 UAE Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 92 UAE Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Phosphoramidite Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Phosphoramidite Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Phosphoramidite Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Participant's Overview
  • Table 97 Financial Performance
  • Table 98 Key Companies Undergoing Expansions
  • Table 99 Key Companies Undergoing Acquisitions
  • Table 100 Key Companies Undergoing Collaborations
  • Table 101 Key Companies Launching New Products
  • Table 102 Key Companies Undertaking Other Strategies

List of Figures

  • Fig. 1 Phosphoramidite market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Phosphoramidite market driver analysis
  • Fig. 12 Phosphoramidite market restraint analysis
  • Fig. 13 Phosphoramidite market: Porter's analysis
  • Fig. 14 Phosphoramidite market: PESTEL analysis
  • Fig. 15 Phosphoramidite market: Type outlook and key takeaways
  • Fig. 16 Phosphoramidite market: Type market share analysis, 2024 - 2033
  • Fig. 17 Global phosphoramidite, by DNA phosphoramidites market, 2021 - 2033 (USD Million)
  • Fig. 18 Global phosphoramidite, by RNA phosphoramidites market, 2021 - 2033 (USD Million)
  • Fig. 19 Global phosphoramidite, by labeled phosphoramidites market, 2021 - 2033 (USD Million)
  • Fig. 20 Global phosphoramidite, by modifier phosphoramidites market, 2021 - 2033 (USD Million)
  • Fig. 21 Global phosphoramidite, by others market, 2021 - 2033 (USD Million)
  • Fig. 22 Phosphoramidite market: Application outlook and key takeaways
  • Fig. 23 Phosphoramidite market: Application market share analysis, 2024 - 2033
  • Fig. 24 Global phosphoramidite, by drug discovery & development market, 2021 - 2033 (USD Million)
  • Fig. 25 Global phosphoramidite, by diagnostics development market, 2021 - 2033 (USD Million)
  • Fig. 26 Global phosphoramidite, by others market, 2021 - 2033 (USD Million)
  • Fig. 27 Phosphoramidite market: End Use outlook and key takeaways
  • Fig. 28 Phosphoramidite market: End Use market share analysis, 2024 - 2033
  • Fig. 29 Global phosphoramidite, by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 Global phosphoramidite, by academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 31 Global phosphoramidite, by others market, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Canada phosphoramidite market, 2021 - 2033 (USD Million)
  • Fig. 36 Mexico phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Europe phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 UK phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Germany phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 France phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Italy phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Spain phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Denmark phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Sweden phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Norway phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Asia-Pacific phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Japan phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 China phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 India phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Australia phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Thailand phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Latin America phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Brazil phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Argentina phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 MEA phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 South Africa phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Saudi Arabia phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 UAE phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Kuwait phosphoramidite market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Key company categorization
  • Fig. 62 Company market positioning
  • Fig. 63 Market participant categorization
  • Fig. 64 Strategy framework
目次
Product Code: GVR-4-68040-310-0

Phosphoramidite Market Summary

The global phosphoramidite market size was estimated at USD 1.15 billion in 2024 and is projected to reach USD 2.27 billion by 2033, growing at a CAGR of 8.06% from 2025 to 2033. The market growth can be attributed to the increasing demand for phosphoramidite in the production of oligonucleotides, the rising prevalence of genetic disorders and infectious diseases has led to a surge in research and development activities in the biotechnology and pharmaceutical industries, which further fuels the demand for phosphoramidite.

Moreover, the growing geriatric population and increasing healthcare expenditure are also expected to drive the market growth in the coming years.

Rising Demand for Oligonucleotide Therapeutics

The increasing adoption of oligonucleotide-based therapeutics is a major growth driver for the phosphoramidite industry. Pharmaceutical and biotechnology companies are investing heavily in the development of antisense oligonucleotides (ASOs), small interfering RNAs (siRNA), and messenger RNA (mRNA) therapies to address a wide range of genetic, infectious, and rare diseases. These therapies rely on precisely synthesized oligonucleotides, with phosphoramidites serving as the essential chemical intermediates for constructing nucleotide chains. The success of mRNA vaccines during the COVID-19 pandemic has further validated the therapeutic potential of synthetic RNA, accelerating research and regulatory acceptance of oligo-based modalities.

ASOs and siRNAs are gaining prominence as next-generation therapeutics due to their ability to selectively silence or modulate gene expression. Multiple ASO-based drugs have already received regulatory approvals, and a robust pipeline is in development targeting neurological disorders, cancers, and metabolic conditions. As the therapeutic landscape shifts towards nucleic acid-based solutions, the demand for high-purity, modified, and scalable phosphoramidites is growing exponentially. Drug developers require consistent and high-quality oligonucleotides that meet stringent regulatory standards for safety and efficacy, thereby increasing reliance on trusted suppliers with proven synthesis capabilities.

In addition, mRNA therapeutics are being explored beyond vaccines, including applications in oncology, cardiovascular diseases, and protein replacement therapies. These advancements demand more complex and specialized phosphoramidites for coding sequences, modified caps, and regulatory elements. This trend is prompting strategic partnerships between oligo manufacturers and pharmaceutical innovators to ensure secure supply chains, technological integration, and quality assurance. With the global pipeline for nucleic acid drugs expanding and clinical trials accelerating, the phosphoramidite industry is well-positioned for long-term growth as a foundational enabler of oligonucleotide therapeutics.

Global Phosphoramidite Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global phosphoramidite market based on type, application, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Phosphoramidites
  • RNA Phosphoramidites
  • Labeled Phosphoramidites
  • Modifier Phosphoramidites
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Diagnostics Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growth of oligonucleotide therapies
      • 3.2.1.2. Advancements in genomics and personalized medicine
      • 3.2.1.3. Growth in synthetic biology research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulations for oligonucleotide therapies
      • 3.2.2.2. Difficulties in long chain synthesis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Phosphoramidite Market: Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Global Phosphoramidite Market Type Movement Analysis
  • 4.3. Global Phosphoramidite Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. DNA Phosphoramidites
    • 4.4.1. Global DNA Phosphoramidites Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. RNA Phosphoramidites
    • 4.5.1. Global RNA Phosphoramidites Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Labeled Phosphoramidites
    • 4.6.1. Global Labeled Phosphoramidites Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Modifier Phosphoramidites
    • 4.7.1. Global Modifier Phosphoramidites Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Phosphoramidite Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Phosphoramidite Market Application, Movement Analysis
  • 5.3. Global Phosphoramidite Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Global Drug Discovery & DevelopmentMarket Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diagnostics Development
    • 5.5.1. Global Diagnostics Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Phosphoramidite Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Phosphoramidite Market End Use Movement Analysis
  • 6.3. Global Phosphoramidite Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Phosphoramidite Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Phosphoramidite Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Participant's Overview
    • 8.4.1. BOC Sciences
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Glen Research
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. LGC Biosearch Technologies
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Biosynth
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. BIONEER CORPORATION
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. QIAGEN
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. PolyOrg, Inc
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Lumiprobe Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives